Middle-age hearing loss linked to dementia. Say again?

The News: Hearing loss in middle age is associated with higher odds of cognitive decline and dementia in later years, suggests a large study in Taiwan. Researchers tracked more than… Read more »

All three of the world’s major drug regulators have busy week despite heat waves, political chaos. You know; the usual.

Last week was a rare case where the world’s leading drugs and devices regulators were all in action simultaneously. The US Food and Drug Administration (FDA), the European Medicines Agency… Read more »

Pace of health-sector IPO action finally slows, but deal sizes grow, proving lots of cash still parked on the sidelines.

Three tech companies in the health sector entered the public market last week, raising a total of $601 million. Here are the proud IPOs and a glance at this week’s… Read more »

July’s IPO action in health sector foreshadows record month of pricings.

The second week of July continued the stampede among healthcare startups and seasoned players in search of new funding from Wall Street and, in one case, the Hong Kong exchange…. Read more »

European drug regulator comes out of hibernation in new Dutch headquarters, rivaling the FDA with rulings; well, just for one week.

It may have taken nearly 6 months and perhaps a Fourth of July holiday-shortened work week here in the US, but the European Medicines Agency (EMA) finally issued some new… Read more »